SUMMARY A method for the measurement of circulating ferritin concentrations by direct radioimmunoassay is presented. The method described is simple to operate, precise, and sensitive and is suitable for the routine diagnostic measurement of ferritin in either plasma or serum.
Ferritin is the major intracellular iron storage protein found in the body, consisting of a spherical protein shell of MW 450 000 made up of 24 identical subunits. Iron is stored in the inner core as crystalline ferric-oxide-phosphate. Ferritin is found mainly in the reticuloendothelial system, predominantly in the spleen, liver, and bone marrow. Circulating levels of ferritin have been shown to reflect the total body iron stores in most clinical situations (Walters et al., 1973; Bentley and Williams, 1974) with the exception of familial varieties of haemochromatosis (Wands et al., 1976) .
A number of sensitive radioisotopic assays have now been described for measuring ferritin in plasma or serum. All have been based on an immunoradiometric technique in which the antibody to ferritin is labelled with iodine-125 (Addison et al., 1972; Miles et al., 1974; Halliday et al., 1975) . The major advantage of this immunoradiometric technique over previously described methods is that it is sensitive enough to measure normal circulating levels of ferritin. Unfortunately, like many immunoradiometric methods, this technique may be time-consuming and imprecise and show inter-assay variation in results. Recent radioimmunoassays have been described for use in man in which ferritin itself was labelled with 125I (Marcus and Zinberg, 1975; Luxton et al., 1977) .
The present paper confirms and extends the use of direct radioimmunoassays for measuring ferritin in human serum or plasma. This technique is sufficiently sensitive to detect circulating levels within the normal range, it is easier to perform, and is more reproducible and economical than the immunoradiometric methods in current use. of the technique described by Hunter and Greenwood (1962) . Ten microgrammes of ferritin in 10 pl PBS and 10 jd of 0 4 M phosphate buffer, pH 7T4, was added to 1 mCi sodium 1251 (Code No. IMS 30, Radiochemical Centre, Amersham) in a tapered polystyrene tube followed by 10 ,ul PBS containing 50 ,pg chloramine-T. After mixing for 30 seconds a further 20 ,ul PBS containing 60 jig sodium metabisulphite was added, followed by 100 ul assay diluent. The percentage incorporation of 125I into protein for each radioiodination was calculated using paper wick chromatography (0rskov, 1967) . Five microlitres of the iodination reaction mixture was applied to a strip of Gelman paper (3-8 x 11). The wick was placed in a test tube containing 1 ml 5% trichloroacetic acid for 15 minutes. The paper was then cut into 1-cm strips, and the radioactivity was counted.
The iodination reaction mixture was purified by gel-filtration using an Agarose A5-m column eluted with assay diluent. The immunoreactivity of the labelled products in the column fractions was assessed by determining the percentage that was bound by an excess of antihuman ferritin antibody (Fig. 1) . Fifty microlitres of each fraction was diluted in 1 ml assay diluent, and 100 pl of this was added to 100 pl of antiferritin antiserum to give a final antiserum dilution of 1:1000. After incubation for 2 h at 370C the antibody bound and free protein were separated as described below. Control tubes containing no antiserum but the same concentration (1:1000) of normal serum (NRS) were included. The fractions containing the highest immunoreactivity were pooled, divided into aliquots, and stored at -20'C. The binding was assessed on each aliquot, after thawing, before use in the assay to assess the stability of the 125I-labelled ferritin; however, the final antiserum dilution was increased to 1:2 x 106 to correspond with the conditions used in the routine assay.
SEPARATION OF BOUND AND FREE

125I-LABELLED PROTEIN
The effect of using various concentrations of the different reagents was studied, and the suitability at each concentration was assessed using the criteria of Chard (1971) . The incubation mixture in all the experiments contained 1 ng of 1251-labelled ferritin and a final dilution of antiferritin antibody of 1 :1000 in a final volume of 500 ,ul. Control tubes containing no antibody but a similar concentration (1:1000) of normal rabbit sera (NRS) were included.
In the second antibody precipitation technique, varying concentrations of donkey anti-rabbit serum were added to each tube followed by varying concentrations of normal rabbit serum. After an shown. The first peak was due to iodination-damaged ferritin aggregate, the second to monomeric labelled peptide, and the third to unreacted 125L incubation at 370C for 2 h the reaction tubes were centrifuged at 2500 g for 30 min at 4°C; the supernatant was discarded and the precipitate containing the antibody-bound ferritin was counted.
For the fractional precipitation method, increasing volumes of ethanol or ammonium sulphate (Chard etal., 1971) with the purified human liver ferritin. For both the initial and subsequent booster injections each rabbit received 500 ,ug of ferritin, prepared as a water-in-oil emulsion by mixing two volumes of 0.
--complete Freund's adjuvant (Difco Laboratories, Detroit, Michigan) with one volume of buffered ferritin. One millilitre of this emulsion was injected into multiple subcutaneous sites in the neck at intervals of four to seven weeks. Blood was obtained from an ear vein 28 days after primary immunisation and 14 days after boosting.
The antibody titre of the sera was assessed by measuring the binding to 125I-labelled ferritin. Antiserum dilution curves were constructed by setting up doubling dilutions of the antisera to be tested in 450 ,ul assay diluent, followed by the addition of 50 ,ul of suitable dilution 125I-labelled ferritin (0-5-1 ng). The tubes were incubated for 18 h at 20'C before the addition of second antibody and a further incubation for 2 h at 370C before final separation. Control tubes (diluent blanks) were set up without antiferritin antibody. The titre of the sera was defined as the dilution which bound 50% homologous labelled ferritin.
For the construction of standard curves, 50 ,ul of doubling dilutions of a standard unlabelled ferritin solution (2 5-350 pug/l) were added to 350 pul of the assay diluent followed by 50 ,ul of a suitable dilution of 125I-labelled ferritin (0-5-1P0 ng, 10 000 cpm) in assay diluent also containing 1:1000 normal rabbit sera and, finally 50 ,ul of specific antiserum diluted to give a final dilution ranging from 1 x 104 to 1 x 108. Control tubes were prepared as described above (diluent blank) as well as zero standards (no unlabelled ferritin). The tubes were incubated for 18 h at 4°C before the addition of second antibody and a further incubation of 2 h at 37°C before the final separation of bound and free 125I-labelled ferritin.
PREPARATION OF FERRITIN-FREE SERA
Ferritin-free human sera were prepared by immunoabsorption. Glutaraldehyde cross-linked rabbit antiferritin antibody was prepared according to the method of Avrameas and Ternynck (1969) . The IgG fraction of rabbit antiferritin antiserum was suspended in 0-15 M NaCl and the pH was adjusted to 8-0 with 0-1 M NaOH. A 25 % solution of glutaraldehyde was added to give a final concentration of 1 part protein :10 parts glutaraldehyde, mixed, and left at room temperature for one hour. The conjugated protein was centrifuged, resuspended in 015 M NaCl, and washed. The conjugate was then added in excess to the serum, which had been trace labelled with 1251-labelled ferritin. The serum was mixed at 4°C for 48 h and centrifuged to remove the conjugated IgG-ferritin complex. The effectiveness of ferritin removal was assessed by measuring the concentration of ferritin and by counting the radioactivity before and after conjugation.
SUBJECTS STUDIED AND PROCEDURE
Sixty-five subjects were randomly selected from patients who had had a bone marrow biopsy as a part of a general haematological investigation. The group included patients with iron deficiency anaemia, megaloblastic anaemia, a combination of iron deficiency and megaloblastic anaemia, anaemia of chronic disorder, sideroblastic anaemia, and transfusional haemosiderosis. Patients with leukaemia or other neoplastic diseases were excluded from this series.
Haemoglobin concentration, packed cell volume, erythrocyte count, mean cell volume, mean cell haemoglobin, mean cell haemoglobin concentration, and leucocyte count were determined on sequestrenated blood using a Coulter Counter model S, and the platelets were counted on a Technicon AutoAnalyzer.
Serum iron concentration was measured by an automated micromethod (Garry and Owen, 1967) using a Technicon AutoAnalyzer and the unsaturated iron binding capacity using a semiautomated micromethod with radioactive iron (Brozovic and Copestake, 1969) . The measurement of serum and erythrocyte folate was carried out by a semiautomated microbiological assay using a chloramphenicol-resistant strain of Lactobacillus casei (Millbank et al., 1970) . The vitamin B12 concentration was measured by a microbiological assay using Euglena gracilis Z strain (Anderson, 1964) . Other haematological methods were those described by Dacie and Lewis (1975) . Ferritin in serum was assayed in duplicate, as described above.
ASSESSMENT OF BONE MARROW IRON
Iron, which is stainable by the Prussian blue reaction, is present in the reticulum cells of the bone marrow fragments of normal individuals. The amount of this intracellular iron in the bone marrow fragments can be used as a guide to the state of the iron stores of the body (Gale et al., 1963 (Fig. 1) . Protein-bound radioactivity was confined to the first two peaks, as judged by the binding in antibody excess. The third peak was unreacted iodine. The first small peak of radioactivity showed high non-specific binding in the absence of antibody and probably represented aggregated material. The second, larger peak, however, demonstrated a low non-specific binding, and the maximum immunoreactivity occurred on the ascending limb of the peak. This probably represented intact monomeric ferritin, whereas in the descending portion of the peak degradation had probably taken place.
The '25I-labelled ferritin was stable for at least one month, as judged by its immunoreactivity. After this time there was a decrease in the binding of 125I-labelled ferritin with a concomitant rise in the non-specific binding (Fig. 2) . Gel-filtration of the label stored at -200C for 60 days showed aggregation of the ferritin molecule, which accounted for the increase in non-specific binding, but the addition of disaggregating agents, storage at alternative temperatures, or freeze-drying did not enhance the stability of the preparation. was removed by treating two human sera with glutaraldehyde-conjugated IgG specific to human ferritin. Ferritin could not be demonstrated by radioimmunoassay after such treatment, and less than 10% of the added radioactivity could be detected after immunoadsorption. Standard curves using both preparations of ferritin-free sera for the dilution of the standards were identical.
EVALUATION OF ANTISERA AND SENSITIVITY OF ASSAY All rabbits developed antibodies, and in each case the titre rose after booster injections. The highest titres, defined as 50% binding with respect to homologous labelled ferritin, ranged from 2 x 106 to 2 x 107.
A series of standard curves was tested against varying dilutions of antiserum ranging from 1 in 1 x 104 to 1 in 1 x 108. When a final concentration of 1 in 2 x 106 antibody was used with labelled ferritin sufficient to give 10 000 cpm (0 5-l ng) and with a first incubation of 16 h at 40C, the results of 10 consecutive assays (mean ± SD) showed a detection limit of 5 tkg/l (Fig. 3) . This dilution was used for the measurement of ferritin in serum in normal subjects with standards which ranged from 2'5 to 350 ug/l. If the circulating level of ferritin was above 350 pg/l the samples were further diluted in ferritin-free serum and reassayed.
Quality control sera were included in every assay for the assessment of inter-assay and intra-assay variation. The intra-assay coefficient of variation of sera with ferritin concentrations of 15, 40, and 56 pug/l, each assayed 10 times, were 8-0, 2-7, and 1 8% respectively. The inter-assay coefficients of variation of four sera assayed in duplicate on 20 occasions with ferritin concentrations of 10, 33, 51, and 108 ,ug/l were 14, 6, 5, and 3%, respectively, over a six-month period.
Ten serum samples with starting values greater than 350 pg/l were subjected to a series of doubling dilutions in both buffer and ferritin-free serum. The dose response curves in both buffer and serum were parallel on visual inspection to those found when the purified ferritin standards were assayed. Six recovery experiments were performed by the addition of between 25 and 220 ,ug/l ferritin to the normal assay standards. The median recovery was 103 % and the range was 88 to 122%.
RELATIONSHIP BETWEEN SERUM FERRITIN AND IRON STATUS
The 65 patients studied were classified into four groups according to the amount of iron present in their bone marrow using the following grades. Twenty-one patients were grade 0, eight patients were grade 1 +, 29 were grade 2 +, and the remaining seven were grade 3 +. The ferritin levels in each group are shown in Figure 4 . There was a progressive increase in the serum ferritin levels between grade 0 and grade 3 + bone marrow iron stains, and although there was some overlap between grades 1+ and 2 + and between grades 2 + and 3 +, no overlap existed when grade 0 was compared with either grade 1 + or 3+. The single patient in grade 2 + with a serum ferritin level less than 5 ,ug/l suffered from a pyrexia of unknown origin, and the discrepancy could not easily be explained.
Discussion
The present paper confirms and extends the use of a direct radioimmunoassay for the measurement of !c N circulating levels of ferritin in human serum or plasma (Marcus and Zinberg, 1975; Luxton et al., 1977) . However, the assay described here is con-0 j siderably more sensitive than that described by Marcus and Zinberg (1975) , and this is the first time that a comparison has been made between serum ferritin levels measured by direct radioc 2. considerable difficulties occurred during the iodination with chloramine-T, and the resultant aggregated material interfered with the performance of the radioimmunoassay by creating high blank values and 'background' noise. Secondly, optimal incorporation of the 125I during the chloramine-T reaction was dependent upon the starting concentration of ferritin, and 1 ,g/,l was found to be optimal. In addition, the purification of the iodinated material had to be carefully performed in order to remove the aggregate and to isolate the monomer peak. Thirdly, it was necessary to repeat the iodination every four weeks because of an increase in the blank value. Apart from the difficulties described above the assay proved to be exceedingly stable and resilient, with a low inter-assay coefficient of variation. It was possible to prepare large batches of both standards and diluted antisera which appeared to be stable for at least six months. Although the second antibody separation technique required a two-hour incubation this could be reduced to five minutes by the addition of low concentrations of polyethylene glycol (Luxton et al., 1977) . The preparation of highly specific and avid antisera presented no difficulty whatever, and the final dilution used in the routine assay was 1 in 2 x 106.
Serum ferritin in normal individuals is heterogenous and contains isoferritins characteristic of both liver and spleen apoferritin (Drysdale et al., 1977) . The method described uses human liver as a source of ferritin for the tracer and standards, and in the production of antibodies. We have assumed, on the basis of the work of Drysdale and others, that splenic tissues could have been used as the source of ferritin.
In the patients studied, this assay showed that there was a good correlation between serum ferritin levels and stainable bone marrow iron. This has previously been described using an immunoradiometric method for the measurement of serum ferritin (Bentley and Williams, 1974; Hussein et al., 1975) . The data presented suggest that the direct radioimmunoassay provided a reliable, precise, and robust method for the estimation of circulating levels of ferritin for use in the diagnosis of iron deficiency.
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